Metabolomics as a Tool for Discovery – PLOS | ONE article
Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children
The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age.
Read the Full Publication
Posters & Publications
- Studies have consistently shown that earlier diagnosis of #autism spectrum disorder helps kids achieve better outco… https://t.co/63zYtqetpC16 hours ago
- Eye-tracking technology helped researchers at the University of Kent gauge the reactions of adults with #autism to… https://t.co/OagWfJuLLpyesterday
- MRIs can be stressful for anyone, and they’re especially hard for patients with autism spectrum disorder. Researche… https://t.co/QyvEd0bvKT2 days ago